Helio Display Materials has expanded its R&D laboratory space at The Oxford Trust’s Wood Centre for Innovation in Headington to accommodate rapid company growth.
The early-stage drug discovery company with operations in Oxford and Boston is looking to increase its drug discovery and validation capabilities in key neuro disease areas.
Helio Display Materials, the first joint Oxford and Cambridge university spin-out is creating a new generation of brighter, more colourful displays that use significantly less power.
The early-stage science and technology start-up businesses have taken space, as Oxford continues to see strong demand from businesses needing R&D labs, technical workspace and flexible office space.
The funding will allow The Oxford Trust to commence the conversion of dedicated high spec laboratory facilities with 3,000 sq ft of laboratory and close to 9,000 sq ft of allied space.
The class II labs answer the significant demand from science and tech start-ups and SMEs for lab space in Oxford’s world-leading life sciences cluster in Headington.
Biotech start-up, DJS Antibodies, is the second company to move into the newly converted class II laboratory space at The Oxford Trust’s Wood Centre for Innovation.
The arrival of G7 health ministers to Oxford on Thursday 03 June will shine a spotlight on Oxfordshire’s considerable achievements in the life sciences sector.
The project will deliver laboratory facilities in response to the demand from science and tech start-ups and SMEs for lab space in Oxford’s Health and Life Sciences District.